ArticleCureus2025
Efficacy of Modified Triple Assessment in Diagnosing Breast Lesions: A Prospective Observational Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast lumps are a common clinical presentation, often causing significant anxiety due to the risk of malignancy. Early and accurate differentiation between benign and malignant breast lesions is essential for optimal patient management. The modified triple test (MTT), which replaces mammography with ultrasound in the traditional triple assessment test (TAT), offers a more effective diagnostic approach, particularly in younger women with dense breast tissue. This study evaluates the efficacy of MTT in diagnosing breast lesions.
methodsA prospective observational study was conducted on 100 female patients aged 15 years and above presenting with palpable breast lumps at South Central Railway Hospital, Secunderabad, India. Patients underwent clinical examination, ultrasound (USG), and fine-needle aspiration cytology (FNAC), with histopathological examination (HPE) as the gold standard. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each modality.
resultsThe majority of participants were in the 41-50 years age group (38%). Clinical examination demonstrated a sensitivity of 73.08% and specificity of 98.65%. Ultrasound exhibited a sensitivity of 57.69% and specificity of 98.64%. FNAC showed a sensitivity of 84.62% and specificity of 98.65%. MTT demonstrated 100% sensitivity, 98.65% specificity, and 96.30% PPV, significantly outperforming individual modalities.
conclusionThe MTT is a highly accurate and reliable diagnostic approach for breast lump evaluation, reducing the need for unnecessary biopsies. Its high sensitivity and specificity make it a valuable tool for early breast cancer detection, especially in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.